Praxis Investment Management Inc. Has $772,000 Stake in Axon Enterprise, Inc $AXON

Praxis Investment Management Inc. lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 49.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,360 shares of the biotechnology company’s stock after selling 1,340 shares during the period. Praxis Investment Management Inc.’s holdings in Axon Enterprise were worth $772,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new position in Axon Enterprise during the 3rd quarter valued at about $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the 3rd quarter valued at about $29,000. Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $37,000. Root Financial Partners LLC bought a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $34,000. Finally, Sound Income Strategies LLC lifted its position in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Company raised 2026 revenue growth guidance to 30%–32% and is targeting about $450M in free cash flow, signaling stronger cash conversion and confidence in demand. Axon raises 2026 revenue growth outlook to 30%-32% while targeting about
• Positive Sentiment: AI and counter‑drone businesses surged: AI product revenue reported up ~700% Y/Y and counter‑drone bookings/revenue rose several hundred percent, providing a new, high‑growth revenue stream beyond Taser and cameras. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Q1 revenue beat: revenue of ~$807M (+34% Y/Y) and strong bookings/ARR commentary underpin the company’s claim of durable growth across software, devices and international markets. Axon reports Q1 2026 revenue of $807 million, up 34% year over year
• Positive Sentiment: Analyst bullishness: JPMorgan raised its price target and kept an overweight stance, reflecting confidence from at least one major sell‑side shop. Benzinga: JPMorgan raises PT to $755
• Neutral Sentiment: Some brokers maintained Buy ratings and high targets (Needham, William Blair), signalling continued conviction but no consensus on valuation. Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
• Neutral Sentiment: Media pieces are debating valuation — analysts’ average recommendations skew optimistic, so investors should weigh runway (AI/counter‑drone) against a stretched multiple. Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: EPS/margin noise: some reports flagged an EPS miss or tariff‑driven margin pressure despite revenue strength, which tempers the beat and raises near‑term margin visibility concerns. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: Some firms trimmed price targets (Citizens/JMP, Piper Sandler lowered targets), reflecting divergent views on valuation and risk — a potential headwind for sentiment. Citizens Jmp lowers PT (TickerReport) Piper Sandler lowers PT (TickerReport)
• Negative Sentiment: Market reaction was mixed—some coverage notes shares slipped at times despite the beat, showing investors are parsing margins, guidance details and valuation. Axon Shares Slip Despite Q1 Results Above Expectations

Axon Enterprise Trading Up 10.6%

NASDAQ:AXON opened at $426.89 on Friday. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $34.40 billion, a PE ratio of 171.44, a price-to-earnings-growth ratio of 8.24 and a beta of 1.44. The firm’s 50 day moving average is $451.93 and its 200 day moving average is $527.52. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.95%. Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.47 EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the sale, the chief executive officer owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Erika Nardini sold 198 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total transaction of $100,302.84. Following the completion of the sale, the director directly owned 1,946 shares in the company, valued at $985,804.68. This trade represents a 9.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,855 shares of company stock worth $7,109,828 in the last three months. Insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on AXON shares. Craig Hallum reissued a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Citizens Jmp dropped their target price on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating on the stock in a research report on Thursday. Royal Bank Of Canada dropped their target price on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Finally, UBS Group dropped their target price on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday. Sixteen equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $722.69.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.